CL2011002535A1 - Método para producir microesferas que comprenden un componente activo encapsulado al interior de una matriz de proteína de suero gelificada; y las microesferas producidas. - Google Patents
Método para producir microesferas que comprenden un componente activo encapsulado al interior de una matriz de proteína de suero gelificada; y las microesferas producidas.Info
- Publication number
- CL2011002535A1 CL2011002535A1 CL2011002535A CL2011002535A CL2011002535A1 CL 2011002535 A1 CL2011002535 A1 CL 2011002535A1 CL 2011002535 A CL2011002535 A CL 2011002535A CL 2011002535 A CL2011002535 A CL 2011002535A CL 2011002535 A1 CL2011002535 A1 CL 2011002535A1
- Authority
- CL
- Chile
- Prior art keywords
- microspheres
- whey protein
- active component
- matrix
- component encapsulated
- Prior art date
Links
- 239000004005 microsphere Substances 0.000 title abstract 4
- 108010046377 Whey Proteins Proteins 0.000 title abstract 2
- 102000007544 Whey Proteins Human genes 0.000 title abstract 2
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- 239000011159 matrix material Substances 0.000 title abstract 2
- 235000021119 whey protein Nutrition 0.000 title abstract 2
- 239000013543 active substance Substances 0.000 abstract 2
- 235000013365 dairy product Nutrition 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 210000000936 intestine Anatomy 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 210000002784 stomach Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
- A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L11/00—Pulses, i.e. fruits of leguminous plants, for production of food; Products from legumes; Preparation or treatment thereof
- A23L11/30—Removing undesirable substances, e.g. bitter substances
- A23L11/34—Removing undesirable substances, e.g. bitter substances using chemical treatment, adsorption or absorption
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/19—Dairy proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/30—Encapsulation of particles, e.g. foodstuff additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
- B01J13/0052—Preparation of gels
- B01J13/0065—Preparation of gels containing an organic phase
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Organic Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Agronomy & Crop Science (AREA)
- Botany (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Manufacturing Of Micro-Capsules (AREA)
Abstract
Método de producción de microesferas que comprende un componente activo encapsulado al interior de una matriz de proteína de suero gelificada; dichas microesferas; formulación que las comprende; un producto lácteo; método de liberación de un agente activo en el tramo inferior del intestino y protección del agente activo durante el paso por el estómago.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16874609P | 2009-04-13 | 2009-04-13 |
Publications (1)
Publication Number | Publication Date |
---|---|
CL2011002535A1 true CL2011002535A1 (es) | 2013-02-01 |
Family
ID=42321200
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL2011002535A CL2011002535A1 (es) | 2009-04-13 | 2011-10-12 | Método para producir microesferas que comprenden un componente activo encapsulado al interior de una matriz de proteína de suero gelificada; y las microesferas producidas. |
Country Status (6)
Country | Link |
---|---|
US (2) | US9089152B2 (es) |
EP (1) | EP2418968B1 (es) |
CA (1) | CA2758620C (es) |
CL (1) | CL2011002535A1 (es) |
ES (1) | ES2564190T3 (es) |
WO (1) | WO2010119041A2 (es) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9788563B2 (en) * | 2011-04-15 | 2017-10-17 | Pepsico, Inc. | Encapsulation system for protection of probiotics during processing |
US9320297B2 (en) * | 2012-03-22 | 2016-04-26 | Lemniscate Innovations Llc | Spherification/reverse spherification automated and integrated system and method |
MX356413B (es) * | 2012-06-07 | 2018-05-29 | Somalogic Inc | Ensayos multiplexados basados en aptámeros. |
US20150299516A1 (en) * | 2012-11-26 | 2015-10-22 | Progel Pty Ltd | Coating composition |
EP2925300B3 (en) | 2012-11-29 | 2020-11-04 | Progel Pty Ltd | Microparticles comprising a probiotic, cross-linkable reagent, a denatured protein, polyol plasticiser and trehalose |
US10449157B2 (en) | 2013-06-12 | 2019-10-22 | Anabio Technologies Limited | Process for producing microcapsules comprising an active component encapsulated, protected and stabilised within a protein shell |
GB201312245D0 (en) * | 2013-07-08 | 2013-08-21 | Gorman Eddie O | An extrusion process |
RU2646788C2 (ru) * | 2014-11-27 | 2018-03-07 | Общество с ограниченной ответственностью "Изварино Фарма" | Применение соли альгината в качестве сорбента липидов, фармацевтическая композиция и лекарственный препарат для лечения ожирения |
AU2015367634B2 (en) * | 2014-12-15 | 2021-05-20 | Teagasc - The Agriculture And Food Development Authority | Gastro-resistant microencapsulates, and uses thereof to stimulate in-vivo ileal GLP-1 release in a mammal |
GB201508745D0 (en) | 2015-05-21 | 2015-07-01 | Anabio Technologies Ltd | A method of producing microparticles of the type having a crosslinked, aggregated protein matrix by spray drying |
FR3048884B1 (fr) * | 2016-03-18 | 2021-07-30 | Capsulae | Composition pour l'administration par voie orale d'au moins un principe actif a un sujet |
WO2017203051A1 (en) | 2016-05-26 | 2017-11-30 | University College Cork - National University Of Ireland, Cork | An engineered gram positive bacterium |
US20200317738A1 (en) | 2016-05-26 | 2020-10-08 | University College Cork - National University Of Ireland, Cork | Methods for increasing proliferation of mammalian cells |
CA3073615A1 (en) | 2017-08-25 | 2019-02-28 | University College Cork - National University Of Ireland Cork | Bifidobacterium longum for treating obesity and weight management |
CA3083711A1 (en) | 2017-11-24 | 2019-05-31 | University College Cork, National University Of Ireland, Cork | A composition comprising a cohort of bacteria |
AU2019232145A1 (en) | 2018-03-07 | 2020-10-01 | Teagasc - The Agriculture And Food Development Authority | A composition for type II diabetics and for use in providing sustained energy release over time |
NL2025932B1 (en) | 2020-06-26 | 2022-02-21 | Iamfluidics Holding B V | Micro-fluidic system and method |
EP3939596A1 (en) | 2020-07-14 | 2022-01-19 | Bimeda Animal Health Limited | A composition for treating helminth infestation in a mammal |
GB202011598D0 (en) | 2020-07-27 | 2020-09-09 | Anabio Tech Limited | A pharmaceutical composition in oral dosage form |
CN111838675A (zh) * | 2020-08-25 | 2020-10-30 | 无限极(中国)有限公司 | 一种制备油脂微球粉体的方法 |
EP4046643A1 (en) | 2021-02-23 | 2022-08-24 | University College Cork - National University of Ireland, Cork | A method of treating or preventing colorectal cancer |
CN112956697B (zh) * | 2021-03-12 | 2023-03-28 | 浙江工商大学 | 鼠李糖乳杆菌微胶囊的制备方法 |
EP4070670A1 (en) | 2021-04-08 | 2022-10-12 | University College Cork-National University of Ireland Cork | Lacticaseibacillus paracasei em025-11 and uses thereof |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4217370A (en) | 1977-08-25 | 1980-08-12 | Blue Wing Corporation | Lipid-containing feed supplements and foodstuffs |
US5750183A (en) * | 1993-11-16 | 1998-05-12 | Takeda Food Products, Ltd. | Process for producing proteinaceous microparticles |
WO1997048288A1 (en) | 1996-06-18 | 1997-12-24 | Bush Boake Allen Inc. | Method of encapsulation and product produced thereby |
EP1234507A1 (en) * | 2001-02-26 | 2002-08-28 | Wageningen Centre for Food Sciences | Process for isolating beta-lactoglobulin from milk or milk fractions |
EP1371410A1 (en) * | 2002-06-14 | 2003-12-17 | NIZO food research | Complex coacervates containing whey proteins |
IL160095A0 (en) | 2004-01-28 | 2004-06-20 | Yissum Res Dev Co | Formulations for poorly soluble drugs |
US20080044481A1 (en) * | 2004-05-27 | 2008-02-21 | Mordechai Harel | Microparticles for Oral Delivery |
WO2007034213A1 (en) * | 2005-09-24 | 2007-03-29 | Cambridge Applied Polymers Limited | Process for encapsulation of edible oil products with whey protein and encapsulated edible oil products |
-
2010
- 2010-04-13 EP EP10726000.2A patent/EP2418968B1/en active Active
- 2010-04-13 WO PCT/EP2010/054846 patent/WO2010119041A2/en active Application Filing
- 2010-04-13 CA CA2758620A patent/CA2758620C/en active Active
- 2010-04-13 ES ES10726000.2T patent/ES2564190T3/es active Active
- 2010-04-13 US US13/264,381 patent/US9089152B2/en active Active
-
2011
- 2011-10-12 CL CL2011002535A patent/CL2011002535A1/es unknown
-
2015
- 2015-07-16 US US14/801,390 patent/US10271569B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
US9089152B2 (en) | 2015-07-28 |
CA2758620A1 (en) | 2010-10-21 |
US20150320097A1 (en) | 2015-11-12 |
ES2564190T3 (es) | 2016-03-18 |
WO2010119041A2 (en) | 2010-10-21 |
US10271569B2 (en) | 2019-04-30 |
WO2010119041A3 (en) | 2011-01-13 |
CA2758620C (en) | 2018-10-16 |
US20120156252A1 (en) | 2012-06-21 |
EP2418968B1 (en) | 2015-12-02 |
EP2418968A2 (en) | 2012-02-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2011002535A1 (es) | Método para producir microesferas que comprenden un componente activo encapsulado al interior de una matriz de proteína de suero gelificada; y las microesferas producidas. | |
CL2013000347A1 (es) | Poblacion de microparticulas que comprenden un corticoesteroide clase b incorporado en una matriz formada por un copolimero de acido lactico y acido glicolico, donde dicho corticoesteroide comprende entre 22% a 28% de las microparticulas; preparacion de liberacion controlada; formulacion; y metodo de fabricacion. | |
WO2017091749A8 (en) | Shape changing drug delivery devices and methods | |
AR077676A1 (es) | Alimento para animales y su apariencia | |
EP4275760A3 (en) | Egg protein formulations and methods of manufacture thereof | |
WO2014165308A3 (en) | Microsphere drug delivery system for sustained intraocular release | |
BR112012023324B8 (pt) | processo de preparação de uma forma de dosagem multifásica liofilizada de dissolução rápida | |
CL2014000759A1 (es) | Composicion para uso en el crecimiento del cerebro y/o desarrollo cognitivo y/o desarrollo psicomotor que comprende al menos un ácido graso poliinsaturado de cadena larga (lc-pufa), al menos un probiótico y una mezcla de oligosacáridos; uso de la composición. | |
EP3861982A3 (en) | Intracameral implant for treatment of an ocular condition | |
WO2014011860A3 (en) | Hydrogel fragrance capsule, formulations and process for preparing the same | |
CO7141411A2 (es) | Formulaciones y métodos para la administración vaginal de antiprogestinas | |
MX2014005997A (es) | Microparticulas de polimero y proteina. | |
BR112014031914A2 (pt) | cápsula de estradiol solúvel para inserção vaginal | |
BRPI1007658A2 (pt) | sistema de travesseiro ativo para manipular as condições de repouso de uma pessoa e método para manipular condições de repouso de uma pessoa | |
WO2016199167A3 (en) | Microcapsules modified with nanomaterial for controlled release of active agent and process for preparation thereof | |
BR112015022161A2 (pt) | implante intraocular contendo prostamida | |
PE20140255A1 (es) | Tableta dispersable en forma oral | |
AR086395A1 (es) | Envase para el tratamiento de patologias | |
BR112013007740A2 (pt) | métodos para processamento de microesferas, microesferas processadas por tais métodos e seus usos | |
BR112012027794A2 (pt) | tablete entérico | |
CL2013002700A1 (es) | Cápsula suave ingerible que contiene inositol y excipientes, o inositol, excipientes y al menos un principio activo adicional, tal como ácido fólico, polifenoles de cocoa, genisteína, l-arginina, vitamina e, selenio, n-acetilcisteína y melatonina; útil para el tratamiento del ovario poliquístico, resistencia a la insulina y otros | |
PH12015502556A1 (en) | Modified release formulation | |
MY191875A (en) | Solid dosage form | |
CA3028338A1 (en) | Microencapsulation of bacteriophages and related products | |
BR112012027782A2 (pt) | tablete entérico |